Sinigrin
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Sinigrin
Description:
Sinigrin (Allyl-glucosinolate) is an orally active glucosinolate found in cruciferous plants. Sinigrin possesses multiple activities such as anti-cancer, antibacterial, antifungal, anti-inflammatory, antioxidant, and inhibition of fat synthesis. Sinigrin can be used in the research of tumors, inflammatory, and metabolic diseases[1][2][3][4].Product Name Alternative:
Allyl-glucosinolate; 2-Propenyl-glucosinolateUNSPSC:
12352005Hazard Statement:
H317Target:
Akt; AMPK; Apoptosis; Bacterial; CDK; Fungal; Interleukin Related; mTOR; p38 MAPK; PI3K; PPAR; Reactive Oxygen Species (ROS)Type:
Natural ProductsRelated Pathways:
Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR; Vitamin D Related/Nuclear ReceptorApplications:
Neuroscience-NeuromodulationField of Research:
Cancer; Infection; Metabolic Disease; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/sinigrin.htmlPurity:
99.97Solubility:
H2O : 25 mg/mL (ultrasonic)Smiles:
O[C@@H]1[C@@H] (O) [C@H] (S/C (CC=C) =N/OS (=O) (O[K]) =O) O[C@H] (CO) [C@H]1OMolecular Formula:
C10H16KNO9S2Molecular Weight:
397.46Precautions:
H317References & Citations:
[1]Lee HW, et al. Inhibitory effect of sinigrin on adipocyte differentiation in 3T3-L1 cells: Involvement of AMPK and MAPK pathways. Biomed Pharmacother. 2018 Jun;102:670-680.|[2]Rama Satya Sri Kotipalli, et al. Sinigrin Attenuates the Dextran Sulfate Sodium-induced Colitis in Mice by Modulating the MAPK Pathway. Inflammation. 2023 Jun;46 (3) :787-807. |[3]Li S, et al. Sinigrin Impedes the Breast Cancer Cell Growth through the Inhibition of PI3K/AKT/mTOR Phosphorylation-Mediated Cell Cycle Arrest. J Environ Pathol Toxicol Oncol. 2022;41 (3) :33-43.|[4]Mazumder A, et al. Sinigrin and Its Therapeutic Benefits. Molecules. 2016 Mar 29;21 (4) :416.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture and light)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
CDK4; CDK6; IL-1; IL-6; PPARγCAS Number:
3952-98-5
